Literature DB >> 23074090

A close examination of healthcare expenditures related to fractures.

Meredith L Kilgore1, Jeffrey R Curtis, Elizabeth Delzell, David J Becker, Tarun Arora, Kenneth G Saag, Michael A Morrisey.   

Abstract

This study evaluated reasons for healthcare expenditures both before and after the occurrence of fractures among Medicare beneficiaries. In a previous study we examined healthcare expenditures in the 6 months before and after fractures. The difference-"incremental" expenditures-provides one estimate of the potentially avoidable costs associated with fractures. We constructed a second estimate of the cost burden-"attributable" expenditures-using only those costs recorded in claims with fracture diagnosis codes. Attributable expenditures accounted for only 24% to 60% of incremental expenditures, depending on the fracture site. We examined health care expenditures between 1999 and 2005 among Medicare beneficiaries who experienced fractures (cases) and among beneficiaries who did not experience fractures (controls), matched to cases on age, race, and sex. We also examined healthcare expenditures for cases and controls for 24 months prior to the fracture index date. When expenditures associated with diagnoses for aftercare, joint pain, and osteoporosis, other musculoskeletal diagnoses, pneumonia, and pressure ulcers were included, the proportion of incremental costs directly attributable to fracture care rose to 72% to 88%. Expenditures prior to fracture were higher for cases than controls, and the rate of increase accelerated over the 12 months prior to the hip fracture. Our findings confirm that the original incremental cost analysis constituted a satisfactory method for estimating avoidable costs associated with fractures. We also conclude that those with fractures had much higher and growing healthcare expenditures in the 12 months prior to the event, compared with age-, race-, and sex-matched controls. This suggests that patterns of healthcare services utilization may provide a means to improve fracture prediction rules.
Copyright © 2013 American Society for Bone and Mineral Research.

Entities:  

Mesh:

Year:  2013        PMID: 23074090     DOI: 10.1002/jbmr.1789

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  7 in total

1.  Cost-Effectiveness of Osteoporosis Screening Strategies for Men.

Authors:  Smita Nayak; Susan L Greenspan
Journal:  J Bone Miner Res       Date:  2016-02-10       Impact factor: 6.741

2.  Impact of radiographic vertebral fractures on inpatient healthcare utilization in older women.

Authors:  Jane A Cauley; Li-Yung Lui; Misti L Paudel; Brent C Taylor; Peggy M Cawthon; Teresa A Hillier; John T Schousboe; Charles E McCulloch; Kristine E Ensrud
Journal:  Bone       Date:  2016-04-27       Impact factor: 4.398

3.  Association between refill compliance to oral bisphosphonate treatment, incident fractures, and health care costs--an analysis using national health databases.

Authors:  K R Olsen; C Hansen; B Abrahamsen
Journal:  Osteoporos Int       Date:  2013-04-20       Impact factor: 4.507

4.  Cost-effectiveness of Screening for Osteoporosis in Older Men With a History of Falls.

Authors:  Kouta Ito
Journal:  JAMA Netw Open       Date:  2020-12-01

5.  Medical expenditures for fragility hip fracture in Japan: a study using the nationwide health insurance claims database.

Authors:  Takahiro Mori; Jun Komiyama; Tomoko Fujii; Masaru Sanuki; Keitaro Kume; Genta Kato; Yukiko Mori; Hiroaki Ueshima; Hiroki Matsui; Nanako Tamiya; Takehiro Sugiyama
Journal:  Arch Osteoporos       Date:  2022-04-11       Impact factor: 2.617

6.  Financial Implications of Hospital Readmission After Hip Fracture.

Authors:  Stephen L Kates; Edward Shields; Caleb Behrend; Katia K Noyes
Journal:  Geriatr Orthop Surg Rehabil       Date:  2015-09

7.  Estimated expenditures for hip fractures using merged healthcare insurance data for individuals aged ≥ 75 years and long-term care insurance claims data in Japan.

Authors:  Takahiro Mori; Nanako Tamiya; Xueying Jin; Boyoung Jeon; Satoru Yoshie; Katsuya Iijima; Tatsuro Ishizaki
Journal:  Arch Osteoporos       Date:  2018-03-30       Impact factor: 2.617

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.